Experimental Alzheimer's drug shows promise – but there are many hurdles still to overcome

Lightspring/Shutterstock The first drug that can slow the rate of decline in Alzheimer’s patients has been found. The experimental drug, called lecanemab, is an antibody that targets the toxic clumps of amyloid protein associated with the mind-robbing disease. While these results are cause for celebration, there are still significant questionsContinue Reading

Pregnant woman looking despondent.

In high-income countries such as Denmark and the Netherlands, pregnancy is comparatively safe. But maternal deaths still happen and in places like the UK are increasing. Understanding why is important, not only for the family a woman leaves behind but for the services who provided her care and society moreContinue Reading